Clinical Trial Update: Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing gemcitabine alone versus gemcitabine with cisplatin for advanced pancreatic cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Istituti Tumori Giovanni Paolo II | Conditions: Pancreatic Cancer | Phase 3 | Status: UNKNOWN